{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T22:35:23Z","timestamp":1793831723025,"version":"4.6.1"},"reference-count":98,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1186\/s12967-015-0614-x","type":"journal-article","created":{"date-parts":[[2015,7,31]],"date-time":"2015-07-31T10:42:50Z","timestamp":1438339370000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":117,"title":["Pleiotropic effect of the proton pump inhibitor esomeprazole leading to suppression of lung inflammation and fibrosis"],"prefix":"10.1186","volume":"13","author":[{"given":"Yohannes T","family":"Ghebremariam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John P","family":"Cooke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Gerhart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carol","family":"Griego","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremy B","family":"Brower","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melanie","family":"Doyle-Eisele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin C","family":"Moeller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingtao","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lawrence","family":"Ho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joao","family":"de Andrade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ganesh","family":"Raghu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leif","family":"Peterson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreana","family":"Rivera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Glenn D","family":"Rosen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,8,1]]},"reference":[{"key":"614_CR1","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/S2213-2600(14)70101-8","volume":"2","author":"G Raghu","year":"2014","unstructured":"Raghu G, Chen SY, Yeh WS, Maroni B, Li Q, Lee YC et al (2014) Idiopathic pulmonary fibrosis in us medicare beneficiaries aged 65\u00a0years and older: incidence, prevalence, and survival, 2001\u201311. Lancet Respir Med 2:566\u2013572","journal-title":"Lancet Respir Med"},{"key":"614_CR2","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1136\/thorax.57.4.338","volume":"57","author":"U Hodgson","year":"2002","unstructured":"Hodgson U, Laitinen T, Tukiainen P (2002) Nationwide prevalence of sporadic and familial idiopathic pulmonary fibrosis: evidence of founder effect among multiplex families in finland. Thorax 57:338\u2013342","journal-title":"Thorax"},{"key":"614_CR3","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1136\/thorax.55.2.143","volume":"55","author":"RP Marshall","year":"2000","unstructured":"Marshall RP, Puddicombe A, Cookson WO, Laurent GJ (2000) Adult familial cryptogenic fibrosing alveolitis in the united kingdom. Thorax 55:143\u2013146","journal-title":"Thorax"},{"key":"614_CR4","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0025-6196(11)62955-8","volume":"80","author":"HF Nadrous","year":"2005","unstructured":"Nadrous HF, Myers JL, Decker PA, Ryu JH (2005) Idiopathic pulmonary fibrosis in patients younger than 50 years. Mayo Clin Proc 80:37\u201340","journal-title":"Mayo Clin Proc"},{"key":"614_CR5","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1056\/NEJMoa1402582","volume":"370","author":"TE King Jr","year":"2014","unstructured":"King TE Jr, Bradford WZ, Castro-Bernardini S, Fagan EA, Glaspole I, Glassberg MK et al (2014) A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis. N Engl J Med 370:2083\u20132092","journal-title":"N Engl J Med"},{"key":"614_CR6","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1056\/NEJMoa1402584","volume":"370","author":"L Richeldi","year":"2014","unstructured":"Richeldi L, du Bois RM, Raghu G, Azuma A, Brown KK, Costabel U et al (2014) Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis. N Engl J Med 370:2071\u20132082","journal-title":"N Engl J Med"},{"key":"614_CR7","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1378\/chest.129.3.794","volume":"129","author":"G Raghu","year":"2006","unstructured":"Raghu G, Yang ST, Spada C, Hayes J, Pellegrini CA (2006) Sole treatment of acid gastroesophageal reflux in idiopathic pulmonary fibrosis: a case series. Chest 129:794\u2013800","journal-title":"Chest"},{"key":"614_CR8","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1164\/rccm.201101-0138OC","volume":"184","author":"JS Lee","year":"2011","unstructured":"Lee JS, Ryu JH, Elicker BM, Lydell CP, Jones KD, Wolters PJ et al (2011) Gastroesophageal reflux therapy is associated with longer survival in patients with idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 184:1390\u20131394","journal-title":"Am J Respir Crit Care Med"},{"key":"614_CR9","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/S2213-2600(13)70105-X","volume":"1","author":"JCH Lee","year":"2013","unstructured":"Lee JCH, Anstrom KJ, Martinez FJ, Noth I, Roberts RS, Yow E et al (2013) Anti-acid treatment and disease progression in idiopathic pulmonary fibrosis: An analysis of data from three randomised controlled trials. Lancet Respir Med 1:369\u2013376","journal-title":"Lancet Respir Med"},{"key":"614_CR10","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1183\/09031936.06.00037005","volume":"27","author":"G Raghu","year":"2006","unstructured":"Raghu G, Freudenberger TD, Yang S, Curtis JR, Spada C, Hayes J et al (2006) High prevalence of abnormal acid gastro-oesophageal reflux in idiopathic pulmonary fibrosis. Eur Respir J 27:136\u2013142","journal-title":"Eur Respir J"},{"key":"614_CR11","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1007\/s11894-008-0098-4","volume":"10","author":"JM Shin","year":"2008","unstructured":"Shin JM, Sachs G (2008) Pharmacology of proton pump inhibitors. Curr Gastroenterol Rep 10:528\u2013534","journal-title":"Curr Gastroenterol Rep"},{"key":"614_CR12","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1111\/j.1365-2710.2008.00907.x","volume":"33","author":"MR Namazi","year":"2008","unstructured":"Namazi MR, Jowkar F (2008) A succinct review of the general and immunological pharmacologic effects of proton pump inhibitors. J Clin Pharm Ther 33:215\u2013217","journal-title":"J Clin Pharm Ther"},{"key":"614_CR13","doi-asserted-by":"crossref","first-page":"2312","DOI":"10.1007\/s10620-009-0951-9","volume":"54","author":"RR Kedika","year":"2009","unstructured":"Kedika RR, Souza RF, Spechler SJ (2009) Potential anti-inflammatory effects of proton pump inhibitors: a review and discussion of the clinical implications. Dig Dis Sci 54:2312\u20132317","journal-title":"Dig Dis Sci"},{"key":"614_CR14","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1016\/j.bbrc.2006.04.170","volume":"345","author":"JC Becker","year":"2006","unstructured":"Becker JC, Grosser N, Waltke C, Schulz S, Erdmann K, Domschke W et al (2006) Beyond gastric acid reduction: proton pump inhibitors induce heme oxygenase-1 in gastric and endothelial cells. Biochem Biophys Res Commun 345:1014\u20131021","journal-title":"Biochem Biophys Res Commun"},{"key":"614_CR15","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1136\/gut.33.5.617","volume":"33","author":"JH Wandall","year":"1992","unstructured":"Wandall JH (1992) Effects of omeprazole on neutrophil chemotaxis, super oxide production, degranulation, and translocation of cytochrome b-245. Gut 33:617\u2013621","journal-title":"Gut"},{"key":"614_CR16","doi-asserted-by":"crossref","first-page":"357","DOI":"10.3109\/08923970009016425","volume":"22","author":"G Agastya","year":"2000","unstructured":"Agastya G, West BC, Callahan JM (2000) Omeprazole inhibits phagocytosis and acidification of phagolysosomes of normal human neutrophils in vitro. Immunopharmacol Immunotoxicol 22:357\u2013372","journal-title":"Immunopharmacol Immunotoxicol"},{"issue":"Suppl 2","key":"614_CR17","doi-asserted-by":"crossref","first-page":"S93","DOI":"10.1097\/00004836-199506002-00025","volume":"20","author":"M Suzuki","year":"1995","unstructured":"Suzuki M, Nakamura M, Mori M, Miura S, Tsuchiya M, Ishii H (1995) Lansoprazole inhibits oxygen-derived free radical production from neutrophils activated by helicobacter pylori. J Clin Gastroenterol 20(Suppl 2):S93\u2013S96","journal-title":"J Clin Gastroenterol"},{"key":"614_CR18","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/0891-5849(96)00180-3","volume":"21","author":"M Suzuki","year":"1996","unstructured":"Suzuki M, Mori M, Miura S, Suematsu M, Fukumura D, Kimura H et al (1996) Omeprazole attenuates oxygen-derived free radical production from human neutrophils. Free Radic Biol Med 21:727\u2013731","journal-title":"Free Radic Biol Med"},{"key":"614_CR19","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1097\/00003246-200205000-00026","volume":"30","author":"K Zedtwitz-Liebenstein","year":"2002","unstructured":"Zedtwitz-Liebenstein K, Wenisch C, Patruta S, Parschalk B, Daxbock F, Graninger W (2002) Omeprazole treatment diminishes intra- and extracellular neutrophil reactive oxygen production and bactericidal activity. Crit Care Med 30:1118\u20131122","journal-title":"Crit Care Med"},{"key":"614_CR20","first-page":"476","volume":"55","author":"O Handa","year":"2006","unstructured":"Handa O, Yoshida N, Fujita N, Tanaka Y, Ueda M, Takagi T et al (2006) Molecular mechanisms involved in anti-inflammatory effects of proton pump inhibitors. Inflamm Res Off J Eur Histamine Res Soc 55:476\u2013480","journal-title":"Inflamm Res Off J Eur Histamine Res Soc"},{"issue":"Suppl 1","key":"614_CR21","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1046\/j.1365-2036.2000.014s1074.x","volume":"14","author":"N Yoshida","year":"2000","unstructured":"Yoshida N, Yoshikawa T, Tanaka Y, Fujita N, Kassai K, Naito Y et al (2000) A new mechanism for anti-inflammatory actions of proton pump inhibitors\u2013inhibitory effects on neutrophil-endothelial cell interactions. Aliment Pharmacol Ther 14(Suppl 1):74\u201381","journal-title":"Aliment Pharmacol Ther"},{"key":"614_CR22","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1161\/CIRCULATIONAHA.113.003602","volume":"128","author":"YT Ghebremariam","year":"2013","unstructured":"Ghebremariam YT, LePendu P, Lee JC, Erlanson DA, Slaviero A, Shah NH et al (2013) Unexpected effect of proton pump inhibitors: Elevation of the cardiovascular risk factor asymmetric dimethylarginine. Circulation 128:845\u2013853","journal-title":"Circulation"},{"key":"614_CR23","doi-asserted-by":"crossref","first-page":"H3227","DOI":"10.1152\/ajpheart.00998.2007","volume":"293","author":"F Palm","year":"2007","unstructured":"Palm F, Onozato ML, Luo Z, Wilcox CS (2007) Dimethylarginine dimethylaminohydrolase (ddah): expression, regulation, and function in the cardiovascular and renal systems. Am J Physiol Heart Circ Physiol 293:H3227\u2013H3245","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"614_CR24","doi-asserted-by":"crossref","first-page":"87ra53","DOI":"10.1126\/scitranslmed.3001725","volume":"3","author":"SS Pullamsetti","year":"2011","unstructured":"Pullamsetti SS, Savai R, Dumitrascu R, Dahal BK, Wilhelm J, Konigshoff M et al (2011) The role of dimethylarginine dimethylaminohydrolase in idiopathic pulmonary fibrosis. Sci Transl Med 3:87ra53","journal-title":"Sci Transl Med"},{"key":"614_CR25","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1164\/ajrccm.155.5.9154889","volume":"155","author":"D Saleh","year":"1997","unstructured":"Saleh D, Barnes PJ, Giaid A (1997) Increased production of the potent oxidant peroxynitrite in the lungs of patients with idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 155:1763\u20131769","journal-title":"Am J Respir Crit Care Med"},{"key":"614_CR26","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/1465-9921-6-58","volume":"6","author":"T Genovese","year":"2005","unstructured":"Genovese T, Cuzzocrea S, Di Paola R, Failla M, Mazzon E, Sortino MA et al (2005) Inhibition or knock out of inducible nitric oxide synthase result in resistance to bleomycin-induced lung injury. Respir Res 6:58","journal-title":"Respir Res"},{"key":"614_CR27","doi-asserted-by":"crossref","first-page":"8196","DOI":"10.1074\/jbc.M109.025684","volume":"285","author":"W Chang","year":"2010","unstructured":"Chang W, Wei K, Jacobs SS, Upadhyay D, Weill D, Rosen GD (2010) Sparc suppresses apoptosis of idiopathic pulmonary fibrosis fibroblasts through constitutive activation of beta-catenin. J Biol Chem 285:8196\u20138206","journal-title":"J Biol Chem"},{"key":"614_CR28","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1183\/09059180.00001111","volume":"20","author":"CJ Schaefer","year":"2011","unstructured":"Schaefer CJ, Ruhrmund DW, Pan L, Seiwert SD, Kossen K (2011) Antifibrotic activities of pirfenidone in animal models. Eur Respir Rev Off J Eur Respir Soc 20:85\u201397","journal-title":"Eur Respir Rev Off J Eur Respir Soc"},{"key":"614_CR29","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.jchromb.2006.10.074","volume":"848","author":"I Hultman","year":"2007","unstructured":"Hultman I, Stenhoff H, Liljeblad M (2007) Determination of esomeprazole and its two main metabolites in human, rat and dog plasma by liquid chromatography with tandem mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci 848:317\u2013322","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"614_CR30","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1164\/rccm.2009-040GL","volume":"183","author":"G Raghu","year":"2011","unstructured":"Raghu G, Collard HR, Egan JJ, Martinez FJ, Behr J, Brown KK et al (2011) An official ats\/ers\/jrs\/alat statement: idiopathic pulmonary fibrosis: Evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med 183:788\u2013824","journal-title":"Am J Respir Crit Care Med"},{"key":"614_CR31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2307\/3001534","volume":"3","author":"C Eisenhart","year":"1947","unstructured":"Eisenhart C (1947) The assumptions underlying the analysis of variance. Biometrics. 3:1\u201321","journal-title":"Biometrics."},{"key":"614_CR32","unstructured":"Tamhane AC, Dunlop DD(2000) Statistics and data analysis from elementary to intermediate. Prentice Hall, Upper Saddle River, NJ, pp 473\u2013474"},{"key":"614_CR33","doi-asserted-by":"crossref","first-page":"13180","DOI":"10.1073\/pnas.0605669103","volume":"103","author":"KK Kim","year":"2006","unstructured":"Kim KK, Kugler MC, Wolters PJ, Robillard L, Galvez MG, Brumwell AN et al (2006) Alveolar epithelial cell mesenchymal transition develops in vivo during pulmonary fibrosis and is regulated by the extracellular matrix. Proc Natl Acad Sci USA 103:13180\u201313185","journal-title":"Proc Natl Acad Sci USA"},{"key":"614_CR34","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1164\/rccm.200903-0322OC","volume":"180","author":"H Tanjore","year":"2009","unstructured":"Tanjore H, Xu XC, Polosukhin VV, Degryse AL, Li B, Han W et al (2009) Contribution of epithelial-derived fibroblasts to bleomycin-induced lung fibrosis. Am J Respir Crit Care Med 180:657\u2013665","journal-title":"Am J Respir Crit Care Med"},{"key":"614_CR35","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1513\/pats.201203-025AW","volume":"9","author":"C Vancheri","year":"2012","unstructured":"Vancheri C (2012) Idiopathic pulmonary fibrosis: an altered fibroblast proliferation linked to cancer biology. Proc Am Thorac Soc 9:153\u2013157","journal-title":"Proc Am Thorac Soc"},{"key":"614_CR36","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1002\/path.4299","volume":"232","author":"D Mukherjee","year":"2014","unstructured":"Mukherjee D, Coates PJ, Lorimore SA, Wright EG (2014) Responses to ionizing radiation mediated by inflammatory mechanisms. J Pathol 232:289\u2013299","journal-title":"J Pathol"},{"key":"614_CR37","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/BF02034932","volume":"65","author":"J Hay","year":"1991","unstructured":"Hay J, Shahzeidi S, Laurent G (1991) Mechanisms of bleomycin-induced lung damage. Arch Toxicol 65:81\u201394","journal-title":"Arch Toxicol"},{"key":"614_CR38","doi-asserted-by":"crossref","first-page":"L463","DOI":"10.1152\/ajplung.00099.2011","volume":"302","author":"YP Bhandary","year":"2012","unstructured":"Bhandary YP, Shetty SK, Marudamuthu AS, Gyetko MR, Idell S, Gharaee-Kermani M et al (2012) Regulation of alveolar epithelial cell apoptosis and pulmonary fibrosis by coordinate expression of components of the fibrinolytic system. Am J Physiol Lung Cell Mol Physiol 302:L463\u2013L473","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"614_CR39","doi-asserted-by":"crossref","first-page":"61","DOI":"10.2353\/ajpath.2006.051263","volume":"169","author":"K Koli","year":"2006","unstructured":"Koli K, Myllarniemi M, Vuorinen K, Salmenkivi K, Ryynanen MJ, Kinnula VL et al (2006) Bone morphogenetic protein-4 inhibitor gremlin is overexpressed in idiopathic pulmonary fibrosis. Am J Pathol 169:61\u201371","journal-title":"Am J Pathol"},{"key":"614_CR40","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1164\/rccm.200706-945OC","volume":"177","author":"M Myllarniemi","year":"2008","unstructured":"Myllarniemi M, Lindholm P, Ryynanen MJ, Kliment CR, Salmenkivi K, Keski-Oja J et al (2008) Gremlin-mediated decrease in bone morphogenetic protein signaling promotes pulmonary fibrosis. Am J Respir Crit Care Med 177:321\u2013329","journal-title":"Am J Respir Crit Care Med"},{"key":"614_CR41","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1111\/j.1399-0039.2010.01590.x","volume":"77","author":"M Heron","year":"2010","unstructured":"Heron M, Van Moorsel CHM, Grutters JC, Huizinga TWJ, Van der Helm-van Mil AHM, Nagtegaal MM et al (2010) Genetic variation in grem1 is a risk factor for fibrosis in pulmonary sarcoidosis. Tissue Antigens 77:112\u2013117","journal-title":"Tissue Antigens"},{"key":"614_CR42","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0014-5793(96)00155-X","volume":"382","author":"D Lapenna","year":"1996","unstructured":"Lapenna D, de Gioia S, Ciofani G, Festi D, Cuccurullo F (1996) Antioxidant properties of omeprazole. FEBS Lett 382:189\u2013192","journal-title":"FEBS Lett"},{"key":"614_CR43","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1177\/1753465810392264","volume":"5","author":"T Sasaki","year":"2011","unstructured":"Sasaki T, Nakayama K, Yasuda H, Yamaya M (2011) A new strategy with proton pump inhibitors for the prevention of acute exacerbations in copd. Ther Adv Respir Dis 5:91\u2013103","journal-title":"Ther Adv Respir Dis"},{"key":"614_CR44","doi-asserted-by":"crossref","first-page":"10993","DOI":"10.1074\/jbc.M210328200","volume":"278","author":"K Biswas","year":"2003","unstructured":"Biswas K, Bandyopadhyay U, Chattopadhyay I, Varadaraj A, Ali E, Banerjee RK (2003) A novel antioxidant and antiapoptotic role of omeprazole to block gastric ulcer through scavenging of hydroxyl radical. J Biol Chem 278:10993\u201311001","journal-title":"J Biol Chem"},{"key":"614_CR45","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1124\/jpet.109.152702","volume":"331","author":"T Takagi","year":"2009","unstructured":"Takagi T, Naito Y, Okada H, Ishii T, Mizushima K, Akagiri S et al (2009) Lansoprazole, a proton pump inhibitor, mediates anti-inflammatory effect in gastric mucosal cells through the induction of heme oxygenase-1 via activation of nf-e2-related factor 2 and oxidation of kelch-like ech-associating protein 1. J Pharmacol Exp Therap 331:255\u2013264","journal-title":"J Pharmacol Exp Therap"},{"key":"614_CR46","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1164\/ajrccm.165.3.2003149","volume":"165","author":"HD Wang","year":"2002","unstructured":"Wang HD, Yamaya M, Okinaga S, Jia YX, Kamanaka M, Takahashi H et al (2002) Bilirubin ameliorates bleomycin-induced pulmonary fibrosis in rats. Am J Respir Crit Care Med 165:406\u2013411","journal-title":"Am J Respir Crit Care Med"},{"key":"614_CR47","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/S1471-4906(03)00181-9","volume":"24","author":"LE Otterbein","year":"2003","unstructured":"Otterbein LE, Soares MP, Yamashita K, Bach FH (2003) Heme oxygenase-1: unleashing the protective properties of heme. Trends Immunol 24:449\u2013455","journal-title":"Trends Immunol"},{"key":"614_CR48","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1165\/ajrcmb.27.1.4862","volume":"27","author":"D Morse","year":"2002","unstructured":"Morse D, Choi AM (2002) Heme oxygenase-1: the \u201cemerging molecule\u201d has arrived. Am J Respir Cell Mol Biol 27:8\u201316","journal-title":"Am J Respir Cell Mol Biol"},{"key":"614_CR49","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1183\/09031936.00125407","volume":"31","author":"Q Ye","year":"2008","unstructured":"Ye Q, Dalavanga Y, Poulakis N, Sixt SU, Guzman J, Costabel U (2008) Decreased expression of haem oxygenase-1 by alveolar macrophages in idiopathic pulmonary fibrosis. Eur Respir J 31:1030\u20131036","journal-title":"Eur Respir J"},{"key":"614_CR50","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1053\/hupa.2001.28937","volume":"32","author":"E Lakari","year":"2001","unstructured":"Lakari E, Pylkas P, Pietarinen-Runtti P, Paakko P, Soini Y, Kinnula VL (2001) Expression and regulation of hemeoxygenase 1 in healthy human lung and interstitial lung disorders. Hum Pathol 32:1257\u20131263","journal-title":"Hum Pathol"},{"key":"614_CR51","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1089\/10430340260355356","volume":"13","author":"T Tsuburai","year":"2002","unstructured":"Tsuburai T, Suzuki M, Nagashima Y, Suzuki S, Inoue S, Hasiba T et al (2002) Adenovirus-mediated transfer and overexpression of heme oxygenase 1 cdna in lung prevents bleomycin-induced pulmonary fibrosis via a fas-fas ligand-independent pathway. Hum Gene Ther 13:1945\u20131960","journal-title":"Hum Gene Ther"},{"key":"614_CR52","doi-asserted-by":"crossref","first-page":"859235","DOI":"10.1155\/2012\/859235","volume":"2012","author":"M Constantin","year":"2012","unstructured":"Constantin M, Choi AJ, Cloonan SM, Ryter SW (2012) Therapeutic potential of heme oxygenase-1\/carbon monoxide in lung disease. Int J Hypertens 2012:859235","journal-title":"Int J Hypertens"},{"key":"614_CR53","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0306-3623(01)00084-2","volume":"35","author":"A Yesilkaya","year":"2000","unstructured":"Yesilkaya A, Altinayak R, Korgun DK (2000) The antioxidant effect of free bilirubin on cumene-hydroperoxide treated human leukocytes. Gen Pharmacol 35:17\u201320","journal-title":"Gen Pharmacol"},{"key":"614_CR54","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1126\/science.3029864","volume":"235","author":"R Stocker","year":"1987","unstructured":"Stocker R, Yamamoto Y, McDonagh AF, Glazer AN, Ames BN (1987) Bilirubin is an antioxidant of possible physiological importance. Science 235:1043\u20131046","journal-title":"Science"},{"key":"614_CR55","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1038\/74680","volume":"6","author":"LE Otterbein","year":"2000","unstructured":"Otterbein LE, Bach FH, Alam J, Soares M, Tao Lu H, Wysk M (2000) Carbon monoxide has anti-inflammatory effects involving the mitogen-activated protein kinase pathway. Nat Med 6:422\u2013428","journal-title":"Nat Med"},{"key":"614_CR56","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0002-9440(10)62229-8","volume":"166","author":"Z Zhou","year":"2005","unstructured":"Zhou Z, Song R, Fattman CL, Greenhill S, Alber S, Oury TD, Choi AM et al (2005) Carbon monoxide suppresses bleomycin-induced lung fibrosis. Am J Pathol 166:27\u201337","journal-title":"Am J Pathol"},{"key":"614_CR57","unstructured":"Brigham and women\u2019s hospital (2014) Study of inhaled carbon monoxide to treat idiopathic pulmonary fibrosis. Clinical Trials gov (Study Identifier:NCT01214187)"},{"key":"614_CR58","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1097\/MAJ.0b013e31821a9d8e","volume":"341","author":"DF Zoz","year":"2011","unstructured":"Zoz DF, Lawson WE, Blackwell TS (2011) Idiopathic pulmonary fibrosis: a disorder of epithelial cell dysfunction. Am J Med Sci 341:435\u2013438","journal-title":"Am J Med Sci"},{"key":"614_CR59","first-page":"552","volume":"7","author":"KM Akram","year":"2014","unstructured":"Akram KM, Lomas NJ, Forsyth NR, Spiteri MA (2014) Alveolar epithelial cells in idiopathic pulmonary fibrosis display upregulation of trail, dr4 and dr5 expression with simultaneous preferential over-expression of pro-apoptotic marker p53. Int J Clin Exp Pathol 7:552\u2013564","journal-title":"Int J Clin Exp Pathol"},{"key":"614_CR60","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.intimp.2013.07.021","volume":"17","author":"S Huang","year":"2013","unstructured":"Huang S, Chen M, Ding X, Zhang X, Zou X (2013) Proton pump inhibitor selectively suppresses proliferation and restores the chemosensitivity of gastric cancer cells by inhibiting stat3 signaling pathway. Int Immunopharmacol 17:585\u2013592","journal-title":"Int Immunopharmacol"},{"key":"614_CR61","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1016\/S0002-9440(10)62351-6","volume":"166","author":"BC Willis","year":"2005","unstructured":"Willis BC, Liebler JM, Luby-Phelps K, Nicholson AG, Crandall ED, du Bois RM et al (2005) Induction of epithelial-mesenchymal transition in alveolar epithelial cells by transforming growth factor-beta1: potential role in idiopathic pulmonary fibrosis. Am J Pathol 166:1321\u20131332","journal-title":"Am J Pathol"},{"key":"614_CR62","first-page":"517","volume":"18","author":"H Kage","year":"2012","unstructured":"Kage H, Borok Z (2012) Emt and interstitial lung disease: a mysterious relationship. Curr Opin pulm Med 18:517\u2013523","journal-title":"Curr Opin pulm Med"},{"key":"614_CR63","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1164\/rccm.200802-313OC","volume":"178","author":"M Korfei","year":"2008","unstructured":"Korfei M, Ruppert C, Mahavadi P, Henneke I, Markart P, Koch M et al (2008) Epithelial endoplasmic reticulum stress and apoptosis in sporadic idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 178:838\u2013846","journal-title":"Am J Respir Crit Care Med"},{"key":"614_CR64","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1165\/rcmb.4851","volume":"27","author":"R Song","year":"2002","unstructured":"Song R, Mahidhara RS, Liu F, Ning W, Otterbein LE, Choi AM (2002) Carbon monoxide inhibits human airway smooth muscle cell proliferation via mitogen-activated protein kinase pathway. Am J Respir Cell Mol Biol 27:603\u2013610","journal-title":"Am J Respir Cell Mol Biol"},{"key":"614_CR65","doi-asserted-by":"crossref","first-page":"86","DOI":"10.3164\/jcbn.08-267","volume":"45","author":"T Tanigawa","year":"2009","unstructured":"Tanigawa T, Watanabe T, Higuchi K, Machida H, Okazaki H, Yamagami H et al (2009) Lansoprazole, a proton pump inhibitor, suppresses production of tumor necrosis factor-alpha and interleukin-1beta induced by lipopolysaccharide and helicobacter pylori bacterial components in human monocytic cells via inhibition of activation of nuclear factor-kappab and extracellular signal-regulated kinase. J Clin Biochem Nutr 45:86\u201392","journal-title":"J Clin Biochem Nutr"},{"key":"614_CR66","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1161\/01.RES.0000052990.68216.EF","volume":"92","author":"S Ueda","year":"2003","unstructured":"Ueda S, Kato S, Matsuoka H, Kimoto M, Okuda S, Morimatsu M et al (2003) Regulation of cytokine-induced nitric oxide synthesis by asymmetric dimethylarginine: role of dimethylarginine dimethylaminohydrolase. Circ Res 92:226\u2013233","journal-title":"Circ Res"},{"key":"614_CR67","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1002\/path.4127","volume":"229","author":"W Janssen","year":"2013","unstructured":"Janssen W, Pullamsetti SS, Cooke J, Weissmann N, Guenther A, Schermuly RT (2013) The role of dimethylarginine dimethylaminohydrolase (ddah) in pulmonary fibrosis. J Pathol 229:242\u2013249","journal-title":"J Pathol"},{"key":"614_CR68","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.4049\/jimmunol.165.3.1526","volume":"165","author":"A Trifilieff","year":"2000","unstructured":"Trifilieff A, Fujitani Y, Mentz F, Dugas B, Fuentes M, Bertrand C (2000) Inducible nitric oxide synthase inhibitors suppress airway inflammation in mice through down-regulation of chemokine expression. J Immunol 165:1526\u20131533","journal-title":"J Immunol"},{"key":"614_CR69","first-page":"303","volume":"44","author":"J Batra","year":"2007","unstructured":"Batra J, Chatterjee R, Ghosh B (2007) Inducible nitric oxide synthase (inos): role in asthma pathogenesis. Indian J Biochem Biophys 44:303\u2013309","journal-title":"Indian J Biochem Biophys"},{"key":"614_CR70","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.jtcvs.2005.10.014","volume":"131","author":"PA Linden","year":"2006","unstructured":"Linden PA, Gilbert RJ, Yeap BY, Boyle K, Deykin A, Jaklitsch MT et al (2006) Laparoscopic fundoplication in patients with end-stage lung disease awaiting transplantation. J Thorac Cardiovasc Surg 131:438\u2013446","journal-title":"J Thorac Cardiovasc Surg"},{"key":"614_CR71","first-page":"21","volume":"44","author":"D Behera","year":"2002","unstructured":"Behera D, Kaur S, Sathyanarayana G, Bhatnagar A, Majumdar S (2002) Nitric oxide derivative in bronchoalveolar lavage fluid from patients with idiopathic pulmonary fibrosis. Indian J Chest Dis Allied Sci 44:21\u201324","journal-title":"Indian J Chest Dis Allied Sci"},{"key":"614_CR72","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1152\/physrev.00029.2006","volume":"87","author":"P Pacher","year":"2007","unstructured":"Pacher P, Beckman JS, Liaudet L (2007) Nitric oxide and peroxynitrite in health and disease. Physiol Rev 87:315\u2013424","journal-title":"Physiol Rev"},{"key":"614_CR73","first-page":"51","volume":"28","author":"JR Teabeaut 2nd","year":"1952","unstructured":"Teabeaut JR 2nd (1952) Aspiration of gastric contents; an experimental study. Am J Pathol 28:51\u201367","journal-title":"Am J Pathol"},{"key":"614_CR74","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1097\/00000658-196907000-00009","volume":"170","author":"LJ Greenfield","year":"1969","unstructured":"Greenfield LJ, Singleton RP, McCaffree DR, Coalson JJ (1969) Pulmonary effects of experimental graded aspiration of hydrochloric acid. Ann Surg 170:74\u201386","journal-title":"Ann Surg"},{"key":"614_CR75","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/S0016-5085(97)70168-9","volume":"113","author":"HB El-Serag","year":"1997","unstructured":"El-Serag HB, Sonnenberg A (1997) Comorbid occurrence of laryngeal or pulmonary disease with esophagitis in united states military veterans. Gastroenterology 113:755\u2013760","journal-title":"Gastroenterology"},{"key":"614_CR76","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1378\/chest.69.4.512","volume":"69","author":"EE Mays","year":"1976","unstructured":"Mays EE, Dubois JJ, Hamilton GB (1976) Pulmonary fibrosis associated with tracheobronchial aspiration. A study of the frequency of hiatal hernia and gastroesophageal reflux in interstitial pulmonary fibrosis of obscure etiology. Chest 69:512\u2013515","journal-title":"Chest"},{"key":"614_CR77","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/j.dld.2006.05.012","volume":"38","author":"B Salvioli","year":"2006","unstructured":"Salvioli B, Belmonte G, Stanghellini V, Baldi E, Fasano L, Pacilli AM et al (2006) Gastro-oesophageal reflux and interstitial lung disease. Dig Liver Dis 38:879\u2013884","journal-title":"Dig Liver Dis"},{"key":"614_CR78","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1016\/j.jtcvs.2006.09.085","volume":"133","author":"MP Sweet","year":"2007","unstructured":"Sweet MP, Patti MG, Leard LE, Golden JA, Hays SR, Hoopes C et al (2007) Gastroesophageal reflux in patients with idiopathic pulmonary fibrosis referred for lung transplantation. J Thorac Cardiovasc Surg 133:1078\u20131084","journal-title":"J Thorac Cardiovasc Surg"},{"key":"614_CR79","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.amjmed.2009.07.033","volume":"123","author":"JS Lee","year":"2010","unstructured":"Lee JS, Collard HR, Raghu G, Sweet MP, Hays SR, Campos GM et al (2010) Does chronic microaspiration cause idiopathic pulmonary fibrosis? Am J Med 123:304\u2013311","journal-title":"Am J Med"},{"key":"614_CR80","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1164\/ajrccm.158.6.9804105","volume":"158","author":"RW Tobin","year":"1998","unstructured":"Tobin RW, Pope CE 2nd, Pellegrini CA, Emond MJ, Sillery J, Raghu G (1998) Increased prevalence of gastroesophageal reflux in patients with idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 158:1804\u20131808","journal-title":"Am J Respir Crit Care Med"},{"key":"614_CR81","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.thorsurg.2005.04.004","volume":"15","author":"GR Locke 3rd","year":"2005","unstructured":"Locke GR 3rd (2005) Current medical management of gastroesophageal reflux disease. Thorac Surg Clin 15:369\u2013375","journal-title":"Thorac Surg Clin"},{"key":"614_CR82","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1164\/rccm.200602-163OC","volume":"174","author":"G Raghu","year":"2006","unstructured":"Raghu G, Weycker D, Edelsberg J, Bradford WZ, Oster G (2006) Incidence and prevalence of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 174:810\u2013816","journal-title":"Am J Respir Crit Care Med"},{"key":"614_CR83","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1164\/ajrccm.157.4.9707039","volume":"157","author":"AL Katzenstein","year":"1998","unstructured":"Katzenstein AL, Myers JL (1998) Idiopathic pulmonary fibrosis: clinical relevance of pathologic classification. Am J Respir Crit Care Med 157:1301\u20131315","journal-title":"Am J Respir Crit Care Med"},{"key":"614_CR84","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1378\/chest.08-0033","volume":"134","author":"S Trahan","year":"2008","unstructured":"Trahan S, Hanak V, Ryu JH, Myers JL (2008) Role of surgical lung biopsy in separating chronic hypersensitivity pneumonia from usual interstitial pneumonia\/idiopathic pulmonary fibrosis: analysis of 31 biopsies from 15 patients. Chest 134:126\u2013132","journal-title":"Chest"},{"key":"614_CR85","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/j.rmed.2008.11.001","volume":"103","author":"J Gribbin","year":"2009","unstructured":"Gribbin J, Hubbard R, Smith C (2009) Role of diabetes mellitus and gastro-oesophageal reflux in the aetiology of idiopathic pulmonary fibrosis. Respir Med 103:927\u2013931","journal-title":"Respir Med"},{"key":"614_CR86","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1590\/S1806-37132009001200004","volume":"35","author":"CD Bandeira","year":"2009","unstructured":"Bandeira CD, Rubin AS, Cardoso PF, Moreira Jda S, Machado Mda M (2009) Prevalence of gastroesophageal reflux disease in patients with idiopathic pulmonary fibrosis. J Bras Pneumol 35:1182\u20131189","journal-title":"J Bras Pneumol"},{"key":"614_CR87","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1016\/j.gassur.2005.06.027","volume":"9","author":"MG Patti","year":"2005","unstructured":"Patti MG, Tedesco P, Golden J, Hays S, Hoopes C, Meneghetti A, Damani T et al (2005) Idiopathic pulmonary fibrosis: How often is it really idiopathic? J Gastrointest Surg. 9:1053\u20131056 discussion 1056\u20131058","journal-title":"J Gastrointest Surg."},{"key":"614_CR88","doi-asserted-by":"crossref","first-page":"6","DOI":"10.7326\/0003-4819-121-1-199407010-00002","volume":"121","author":"MB Troshinsky","year":"1994","unstructured":"Troshinsky MB, Kane GC, Varga J, Cater JR, Fish JE, Jimenez SA et al (1994) Pulmonary function and gastroesophageal reflux in systemic sclerosis. Ann Intern Med 121:6\u201310","journal-title":"Ann Intern Med"},{"key":"614_CR89","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1164\/rccm.201110-1842ED","volume":"184","author":"G Raghu","year":"2011","unstructured":"Raghu G (2011) Idiopathic pulmonary fibrosis: increased survival with \u201cgastroesophageal reflux therapy\u201d: fact or fallacy? Am J Respir Crit Care Med 184:1330\u20131332","journal-title":"Am J Respir Crit Care Med"},{"key":"614_CR90","doi-asserted-by":"crossref","first-page":"6292","DOI":"10.1073\/pnas.092134099","volume":"99","author":"F Zuo","year":"2002","unstructured":"Zuo F, Kaminski N, Eugui E, Allard J, Yakhini Z, Ben-Dor A et al (2002) Gene expression analysis reveals matrilysin as a key regulator of pulmonary fibrosis in mice and humans. Proc Natl Acad Sci USA 99:6292\u20136297","journal-title":"Proc Natl Acad Sci USA"},{"key":"614_CR91","first-page":"A3924","volume":"189","author":"DWLS Ruhrmund","year":"2014","unstructured":"Ruhrmund DWLS, Qin X, Arfsten AE, Hooi L, Kartashov A, Weycker D et al (2014) Matrix metalloproteinase (mmp)-7 predicts mortality in idiopathic pulmonary fibrosis (ipf). Am J Respir Crit Care Med 189:A3924","journal-title":"Am J Respir Crit Care Med"},{"key":"614_CR92","doi-asserted-by":"crossref","first-page":"240ra276","DOI":"10.1126\/scitranslmed.3007096","volume":"6","author":"Y Zhou","year":"2014","unstructured":"Zhou Y, Peng H, Sun H, Peng X, Tang C, Gan Y et al (2014) Chitinase 3-like 1 suppresses injury and promotes fibroproliferative responses in mammalian lung fibrosis. Sci Transl Med. 6:240ra276","journal-title":"Sci Transl Med."},{"key":"614_CR93","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1172\/JCI12568","volume":"107","author":"M Kolb","year":"2001","unstructured":"Kolb M, Margetts PJ, Anthony DC, Pitossi F, Gauldie J (2001) Transient expression of il-1beta induces acute lung injury and chronic repair leading to pulmonary fibrosis. J Clin Invest 107:1529\u20131536","journal-title":"J Clin Invest"},{"key":"614_CR94","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1080\/15476910802085822","volume":"5","author":"DE Sullivan","year":"2008","unstructured":"Sullivan DE, Ferris M, Pociask D, Brody AR (2008) The latent form of tgfbeta(1) is induced by tnfalpha through an erk specific pathway and is activated by asbestos-derived reactive oxygen species in vitro and in vivo. J Immunotoxicol 5:145\u2013149","journal-title":"J Immunotoxicol"},{"key":"614_CR95","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1038\/sj.bjp.0707572","volume":"153","author":"R Farre","year":"2008","unstructured":"Farre R, Sifrim D (2008) Regulation of basal tone, relaxation and contraction of the lower oesophageal sphincter. Relevance to drug discovery for oesophageal disorders. Br J Pharmacol 153:858\u2013869","journal-title":"Br J Pharmacol"},{"key":"614_CR96","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1177\/0192623310388431","volume":"39","author":"S Damsch","year":"2011","unstructured":"Damsch S, Eichenbaum G, Tonelli A, Lammens L, Van den Bulck K, Feyen B et al (2011) Gavage-related reflux in rats: identification, pathogenesis, and toxicological implications (review). Toxicol Pathol 39:348\u2013360","journal-title":"Toxicol Pathol"},{"key":"614_CR97","first-page":"986","volume":"25","author":"YR Hu","year":"2004","unstructured":"Hu YR, Qiao HL, Kan QC (2004) Pharmacokinetics of lansoprazole in chinese healthy subjects in relation to cyp2c19 genotypes. Acta Pharmacol Sin 25:986\u2013990","journal-title":"Acta Pharmacol Sin"},{"key":"614_CR98","doi-asserted-by":"crossref","first-page":"38","DOI":"10.2165\/00003088-199120010-00003","volume":"20","author":"CW Howden","year":"1991","unstructured":"Howden CW (1991) Clinical pharmacology of omeprazole. Clin Pharmacokinet 20:38\u201349","journal-title":"Clin Pharmacokinet"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-015-0614-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,23]],"date-time":"2017-06-23T12:47:41Z","timestamp":1498222061000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.translational-medicine.com\/content\/13\/1\/249"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8,1]]},"references-count":98,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["614"],"URL":"https:\/\/doi.org\/10.1186\/s12967-015-0614-x","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,8,1]]},"article-number":"249"}}